cancer drugs

OHSU Researchers Find Some Costly, Recommended Cancer Treatments Lack Evidence

The scientists raise questions about the influence of the pharmaceutical industry on medical recommendations ultimately adopted by Medicare, Medicaid.

Recommendations for costly new cancer drugs with potentially harmful side effects are often based on flimsy evidence, a new study says.

Subscribe to cancer drugs